Generate Biomedicines, Inc. (GENB) vs DENTSPLY SIRONA Inc. (XRAY)

A side-by-side comparison of Generate Biomedicines, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — GENB vs XRAY

growth of $100 · dividends reinvested · last 1y
GENB +10.0% (+10.0%/yr)XRAY -31.7% (-31.7%/yr)GENB compounded faster over this window
80100120140160Start $100$110$68
GENB XRAY

GENB vs XRAY: by the numbers

  • •GENB is the larger company ($1.80B vs $1.71B market cap).
  • •Both run net losses; XRAY's is the smaller (-14.99% vs -636.99% net margin).
  • •XRAY pays a dividend (3.74% yield), while GENB has no payments in the available dividend history.

Metrics side by side

Valuation

MetricGENBXRAY
Forward P/EN/A5.59
P/S ratioN/A0.47
P/B ratio3.941.26
EV / EBITDAN/A4.43
FCF yieldN/A8.37%

Profitability

MetricGENBXRAY
Gross margin100.00%49.52%
Operating margin-737.04%11.69%
Net margin-636.99%-14.99%
ROEN/A-40.41%
ROIC-94.79%10.03%

Dividends

MetricGENBXRAY
Dividend yieldN/A3.74%

Growth (annualized)

MetricGENBXRAY
Revenue CAGR (5Y)N/A1.96%
FCF CAGR (5Y)N/A-25.74%
Total return CAGR (5Y)N/A-30.27%

Frequently asked

Does GENB or XRAY pay a bigger dividend?
XRAY pays a dividend (3.74% yield), while GENB has no payments in the available dividend history.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.